Jun 07, 2023 / 05:00PM GMT
John Tucker - scPharmaceuticals Inc. - President & CEO
Fantastic. Thanks, Glen, and thanks for hosting us. Yeah. It's really exciting time for us. scPharmaceuticals -- really the name says it all. SC stands for subcutaneous. We use subcutaneous technology, technology we've developed, to deliver drugs that have already been proven safe and effective. But are given in the hospital, which as everyone knows, is the single most, highest cost setting of care. And it's also kind of where the patients have the worse outcomes.
So we've been able to use our technology to take our first product, which is called FUROSCIX. It's a drug-device combination and treats New York Heart Association, Class II and Class III heart failure by reformulating the drug from the IV furosemide into a stable pH-neutral form called FUROSCIX and then developing a way, working with West Pharmaceuticals to deliver a five-hour -- it's got a bolus for the first hour and then four hours of continuous infusion.
We've been able to match, almost identical, the PK profile of the IV. Why is that so important? So right now,
scPharmaceuticals Inc at Jefferies Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot